Product Name: Tafamidis
Description: Tafamidis, also known as Fx-1006 or PF-06291826, is a drug for the amelioration of transthyretin-related hereditary amyloidosis (also familial amyloid polyneuropathy, or FAP), a rare but deadly neurodegenerative disease. The drug was approved by the Euro
CAS NO: 842-07-9 Product: Sudan I
Synonym: Fx-1006; Fx1006; Fx 1006; Fx-1006A; PF-06291826; PF06291826; PF 06291826; Tafamidis; trade name Vyndaqel.
IUPAC Chemical Name: 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
In ChiKey: TXEIIPDJKFWEEC-UHFFFAOYSA-NTRP Channel inhibitors
SMILE Code: O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site：Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22147794
Chemical Formula：C14H7Cl2NO3
ExactMass: 306.9803
Molecular Weight: 308.114
Elemental Analysis: C, 54.58; H, 2.29; Cl, 23.01; N, 4.55; O, 15.58
bet-bromodomain.com
BET Bromodomain Inhibitor
